MARC Record from marc_columbia

LEADER: 02351cam a2200481 i 4500
001 3905520
005 20221026235341.0
008 820401s1980 dcua b f000 0 eng
010 $a 80600130
035 $a(OCoLC)6778542
035 $a(OCoLC)ocm06778542
035 $a(CStRLIN)NYCG82-B15516
035 $9AAH7067HS
035 $a(NNC)3905520
035 $a3905520
040 $dNNC-M
043 $an-us---
050 00 $aRA410.5$b.U54 1980
082 0 $a362.1/068/1$219
110 1 $aUnited States.$bCongress.$bOffice of Technology Assessment.$0http://id.loc.gov/authorities/names/n79006671
245 14 $aThe implications of cost-effectiveness analysis of medical technology.
260 $aWashington, D.C. :$bCongress of the United States, Office of Technology Assessment : for sale by the Supt. of Docs., U.S. Govt. Print. Off.,$c[1980]
300 $avii, 219 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aPrepared for the Senate Committees on Labor and Human Resources and on Finance.
500 $a"August 1980."
500 $a"OTA-H-126."
504 $aBibliography: p. 197-219.
650 0 $aMedical care$xCost effectiveness.$0http://id.loc.gov/authorities/subjects/sh2010101152
650 0 $aMedical innovations$xCost effectiveness.
650 0 $aMedical care$zUnited States$xCost effectiveness.$0http://id.loc.gov/authorities/subjects/sh2010101153
650 0 $aMedical innovations$zUnited States$xCost effectiveness.
650 0 $aMedical policy$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2008107275
650 2 $aCost-Benefit Analysis.$0https://id.nlm.nih.gov/mesh/D003362
650 2 $aEconomics, Medical.$0https://id.nlm.nih.gov/mesh/D004470
650 2 $aHealth Services.$0https://id.nlm.nih.gov/mesh/D006296
650 2 $aMedical Laboratory Science.$0https://id.nlm.nih.gov/mesh/D013677
651 2 $aUnited States.$0https://id.nlm.nih.gov/mesh/D014481
710 1 $aUnited States.$bCongress.$bSenate.$bCommittee on Labor and Human Resources.$0http://id.loc.gov/authorities/names/n80063281
710 1 $aUnited States.$bCongress.$bSenate.$bCommittee on Finance.$0http://id.loc.gov/authorities/names/n78088975
740 0 $aCost-effectiveness analysis of medical technology.
852 00 $boff,hsl$hRA410.5$iUn32 1980